70 likes | 153 Views
Flow of study participants. John J.P. Kastelein, et al. Circulation 2006;114:1729-1735. Dosing and follow-up schedule. John J.P. Kastelein, et al. Circulation 2006;114:1729-1735. Subject Demographics and Baseline Lipid Characteristics*.
E N D
Flow of study participants John J.P. Kastelein, et al. Circulation 2006;114:1729-1735
Dosing and follow-up schedule John J.P. Kastelein, et al. Circulation 2006;114:1729-1735
Subject Demographics and Baseline Lipid Characteristics* John J.P. Kastelein, et al. Circulation 2006;114:1729-1735
Adverse Events Considered Related to Study Medication by Dosage John J.P. Kastelein, et al. Circulation 2006;114:1729-1735
Dose-dependent effect of ISIS 301012 on apoB levels John J.P. Kastelein, et al. Circulation 2006;114:1729-1735
Dose-dependent effect of ISIS 301012 on LDL cholesterol levels John J.P. Kastelein, et al. Circulation 2006;114:1729-1735
ApoB and LDL-C Levels by Mean Percent Change Relative to Baseline* John J.P. Kastelein, et al. Circulation 2006;114:1729-1735